Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 000520163 approvals25 trials

SAMIL PHARMACEUTICAL CO.,LTD

Official website

Founded in 1947 and listed on the KOSPI in 1985, Samil Pharmaceutical focuses on ophthalmology, liver disease, and gastrointestinal prescription drugs, and operates a global ophthalmic CDMO plant in Vietnam.

As of 2026-10-10, SAMIL PHARMACEUTICAL CO.,LTD has 1 Korean MFDS device approval, 162 Korean MFDS drug approvals, 7 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Samil Pharmaceutical was founded in 1947 and listed on the KOSPI in 1985 as a pharmaceutical manufacturing and sales company. It is known for products such as Children's Brufen Syrup, Tearsil Once, and Eyetuomini, and focuses on prescription drugs for ophthalmology, liver disease, and gastrointestinal conditions, combining licensed-in production of original drugs, direct development/manufacturing/sales of generics and improved new drugs (product sales), and direct import and exclusive domestic distribution of original products (merchandise sales). In 2025, consolidated revenue was KRW 210.3 billion, with the pharmaceutical segment accounting for 97.8% and other segments 2.2%, and its Vietnam subsidiary completed a global ophthalmic CDMO plant meeting cGMP and EU-GMP standards in November 2022.

Products & technology

  • 어린이부루펜시럽
  • 티어실원스
  • 아이투오미니

Regulatory approvals

data.go.kr

162 Korean MFDS drug approvals · 1970–2026 / 1 Korean MFDS device approvals · 2002

  • MFDS drugTego-S Tab. 25mg2026-08-11
    Drug · Prescription · Approval202602338
  • MFDS drugTego-S Tab. 50mg2026-08-11
    Drug · Prescription · Approval202602339
  • MFDS drugActiflu Cough Soft Cap.2026-08-03
    Drug · OTC · Notification202602238
  • MFDS drugActiflu Cold Soft Cap.2026-07-27
    Drug · OTC · Notification202602160
  • MFDS drugLACURE Mini Eye Drops 0.15% (Sodium Hyaluronate)2026-06-29
    Drug · Prescription · Approval202601845
  • MFDS drugALTSDUO Tab.2026-03-05
    Drug · Prescription · Approval202600663
  • MFDS drugElafree2026-01-13
    Drug · Prescription · Approval202600113
  • MFDS drugTofajakt Tab. 10mg2025-11-20
    Drug · Prescription · Approval202503025
  • MFDS drugOnedopa Tab. 12.5/50mg2025-09-24
    Drug · Prescription · Approval202502527
  • MFDS drugOnedopa Tab. 25/100mg2025-09-24
    Drug · Prescription · Approval202502528
  • MFDS drugOnedopa Tab. 50/200mg2025-09-24
    Drug · Prescription · Approval202502529
  • MFDS drugActiflunose Caps.2025-06-30
    Drug · OTC · Notification202501617
Show 68 more
  • MFDS drugRevaG SR Tablet 150mg2025-05-28
    Drug · Prescription · Approval202501331
  • MFDS drugLecox tab.2023-08-10
    Drug · Prescription · Approval202302412
  • MFDS drugTenoS Tablet2023-03-15
    Drug · Prescription · Approval202300928
  • MFDS drugJaklin Tab. 5mg2022-07-05
    Drug · Prescription · Approval202202794
  • MFDS drugRevaK Eyedrops2022-06-16
    Drug · Prescription · Approval202202522
  • MFDS drugSandoz Sugammadex Sodium Injection2022-01-20
    Drug · Prescription · Approval202200335
  • MFDS drugEYE2O Mint Eye Drops2021-07-13
    Drug · OTC · Notification202105312
  • MFDS drugNEWCOXIA Tab. 30mgRevoked2021-03-25
    Drug · Prescription · Approval202102620
  • MFDS drugLeflu Tab. 10mg2020-12-22
    Drug · Prescription · Approval202009077
  • MFDS drugLeflu Tab. 20mg2020-12-22
    Drug · Prescription · Approval202009078
  • MFDS drugIcure Ophthalmic DropsRevoked2020-11-09
    Drug · Prescription · Approval202007661
  • MFDS drugEYE2O Blue Eye DropsRevoked2020-09-08
    Drug · OTC · Notification202006233
  • MFDS drugOculevo Ophthalmic Drops 1.5%2020-05-26
    Drug · Prescription · Notification202003807
  • MFDS drugLacure Ophthalmic Drops 0.3%2020-05-21
    Drug · Prescription · Approval202003717
  • MFDS drugAroda Cap.Revoked2020-05-15
    Drug · Prescription · Approval202003529
  • MFDS drugOCUOLO Ophthalmic drops 0.7%2020-04-29
    Drug · Prescription · Approval202003228
  • MFDS drugPolymac Tab.2020-02-21
    Drug · Prescription · Approval202001272
  • MFDS drugSislin Soft Cap.2020-01-29
    Drug · OTC · Notification202000474
  • MFDS drugAlzarl Tab. 10mg2019-11-27
    Drug · Prescription · Notification201908132
  • MFDS drugAlzarl Tab. 5mg2019-11-20
    Drug · Prescription · Notification201908003
  • MFDS drugGilect Tab. 0.5mg2019-10-22
    Drug · Prescription · Approval201907386
  • MFDS drugGilect Tab. 1mg2019-10-22
    Drug · Prescription · Approval201907387
  • MFDS drugGABELIN Tab. 50mg2019-07-29
    Drug · Prescription · Approval201905357
  • MFDS drugGABELIN Tab. 25mg2019-07-29
    Drug · Prescription · Approval201905358
  • MFDS drugTwolion Ophthalmic Drops2019-07-24
    Drug · Prescription · Approval201905273
  • MFDS drugRAVE Tab.Revoked2019-05-31
    Drug · Prescription · Notification201903620
  • MFDS drugOcuporine Ophthalmic Drops 0.05%Revoked2019-05-20
    Drug · Prescription · Approval201903227
  • MFDS drugEntapone Tab. 200mgRevoked2019-04-25
    Drug · Prescription · Approval201902599
  • MFDS drugTIERSIL Aerosol2018-11-28
    Drug · OTC · Notification201804704
  • MFDS drugDualkopt Eye Drops2018-10-31
    Drug · Prescription · Approval201804301
  • MFDS drugPrapexole ER Tab. 0.75mg2018-10-31
    Drug · Prescription · Approval201804306
  • MFDS drugPrapexole ER Tab. 1.5mg2018-10-31
    Drug · Prescription · Approval201804307
  • MFDS drugPrapexole ER Tab. 0.375mg2018-10-31
    Drug · Prescription · Approval201804308
  • MFDS drugDoxilium Tab. 500mg2018-01-15
    Drug · Prescription · Approval201800205
  • MFDS drugMONOPROST Eye Drops2017-12-18
    Drug · Prescription · Approval201708384
  • MFDS drugLinoped Tab.2017-08-11
    Drug · Prescription · Approval201706560
  • MFDS drugGABELIN Tab. 150mg2017-07-20
    Drug · Prescription · Approval201705789
  • MFDS drugGABELIN Tab. 75mg2017-07-20
    Drug · Prescription · Approval201705790
  • MFDS drugAcefen Tab.2017-03-28
    Drug · Prescription · Approval201701471
  • MFDS drugTIERSIL Cool Cream2016-05-30
    Drug · OTC · Notification201603039
  • MFDS drugErecximum ODF 20mg2015-07-13
    Drug · Prescription · Approval201504798
  • MFDS drugExozole Tab. 20mg2015-06-29
    Drug · Prescription · Approval201504200
  • MFDS drugExozole Tab. 40mg2015-06-29
    Drug · Prescription · Approval201504201
  • MFDS drugEommason Syrup2015-04-15
    Drug · OTC · Notification201502255
  • MFDS drugSandoz Escitalopram FCT 5mg2015-02-27
    Drug · Prescription · Approval201501051
  • MFDS drugLividi Cap.2015-01-27
    Drug · Prescription · Approval201500401
  • MFDS drugTrinity White Gel2014-12-15
    Drug · Prescription · Notification201405890
  • MFDS drugSandoz Escitalopram FCT 15mg2014-04-14
    Drug · Prescription · Approval201401785
  • MFDS drugSandoz Escitalopram FCT 20mg2014-04-14
    Drug · Prescription · Approval201401786
  • MFDS drugEperione Tab.2013-08-05
    Drug · Prescription · Approval201308671
  • MFDS drugEnped Tab. 1mg2012-09-24
    Drug · Prescription · Approval201206904
  • MFDS drugEnped Tab. 0.5mg2012-09-24
    Drug · Prescription · Approval201206905
  • MFDS drugMelodex Cap. 15mg2012-09-21
    Drug · Prescription · Approval201206872
  • MFDS drugPrapexole Tab. 0.125mg2012-09-20
    Drug · Prescription · Approval201206856
  • MFDS drugPrapexole Tab. 0.5mg2012-09-20
    Drug · Prescription · Approval201206857
  • MFDS drugPrapexole Tab. 0.25mg2012-09-20
    Drug · Prescription · Approval201206858
  • MFDS drugSandoz Sertraline FCT 100mg2012-09-17
    Drug · Prescription · Approval201206823
  • MFDS drugMelodex Cap. 7.5mg2012-09-11
    Drug · Prescription · Approval201206751
  • MFDS drugPrapexole Tab. 1mg2012-02-28
    Drug · Prescription · Approval201201265
  • MFDS drugHyabak Eye Drops2011-09-30
    Drug · Prescription · Approval201107545
  • MFDS drugEYE2O Mini Eye Drop2011-08-22
    Drug · OTC · Notification201105482
  • MFDS drugTELMIS Plus Tab. 80/25mg2010-09-30
    Drug · Prescription · Notification201005770
  • MFDS drugAlinol Ophthalmic Drops2010-06-29
    Drug · Prescription · Approval201004240
  • MFDS drugTELMIS Tab. 40mg2010-02-25
    Drug · Prescription · Notification201001683
  • MFDS drugTELMIS Tab. 80mg2010-02-25
    Drug · Prescription · Notification201001685
  • MFDS drugTELMIS Plus Tab. 80/12.5mg2010-01-29
    Drug · Prescription · Notification201001021
  • MFDS drugTELMIS Plus Tab. 40/12.5mg2010-01-29
    Drug · Prescription · Notification201001022
  • MFDS drugRovitan Tab. 20mg2010-01-28
    Drug · Prescription · Approval201001006

Showing the 80 most recent of 163 records.

Clinical trials

data.go.kr

25 MFDS clinical trial authorisations · 2014–2025 (Bioequivalence 23 · Phase 1 2)

  • Bioequivalence사피온정50밀리그램(사피나미드메실산염)2025-11-12

    2 trial sites

  • Bioequivalence보넥타정20밀리그램2025-09-01

    2 trial sites

  • Bioequivalence프라펙솔정0.25밀리그램(프라미펙솔염산염일수화물)2025-01-10

    2 trial sites

  • Bioequivalence포리부틴드라이시럽2024-08-26

    2 trial sites

  • BioequivalenceSI-BL2002023-07-10

    2 trial sites

  • Bioequivalence엔페드정1밀리그램(엔테카비르)2023-04-17

    2 trial sites

  • Bioequivalence알잘정10밀리그램(아로티놀롤염산염)2023-02-17

    2 trial sites

  • Bioequivalence포리부틴서방정(트리메부틴말레산염)2022-11-21

    2 trial sites

  • Bioequivalence포리부틴서방정(트리메부틴말레산염)2022-11-03

    2 trial sites

  • Bioequivalence가벨린서방정165밀리그램2021-09-02

    1 trial site

  • Bioequivalence가벨린서방정165밀리그램2021-09-01

    1 trial site

  • Bioequivalence프라펙솔서방정0.375밀리그램(프라미펙솔염산염일수화물)2020-05-14

    2 trial sites

Show 13 more
  • Bioequivalence프라펙솔서방정0.375밀리그램(프라미펙솔염산염일수화물)2020-05-08

    2 trial sites

  • Bioequivalence프라펙솔정0.25밀리그램(프라미펙솔염산염일수화물)2019-11-06

    2 trial sites

  • Bioequivalence길렉트정(라사길린메실산염)2018-08-27

    2 trial sites

  • Bioequivalence엔타폰정(엔타카폰200mg)2018-03-16

    2 trial sites

  • Bioequivalence프라펙솔서방정0.375밀리그램(프라미펙솔염산염일수화물)2017-07-17

    2 trial sites

  • Bioequivalence삼일 BDD&마늘유 복합정(가칭)2016-07-13

    2 trial sites

  • Bioequivalence가벨린정150mg(프레가발린)2016-06-24

    2 trial sites

  • Bioequivalence플루진현탁용분말6mg/mL(오셀타미비르인산염)2015-11-26

    2 trial sites

  • Bioequivalence삼일 텔미사르탄80mg암로디핀5mg복합제(가칭)2015-07-22

    2 trial sites

  • Bioequivalence라노졸정2015-06-23

    2 trial sites

  • Phase 1SI-13022014-05-30

    1 trial site

  • Phase 1SI-13072014-05-30

    1 trial site

  • Bioequivalence엑소졸정 40mg2014-03-19

    2 trial sites

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

Aramchol · 비알콜성지방간염(NASH) · 임상3상 · Licensed from Galmed Research and Development on 2016-07-28; Samil holds Korean sales rights for 20 years after first domestic launch; total milestone payments up to US$8,089,473 (US$3,589,473 paid to date as upfront and milestones).

Lorecivivint (SM04690) · 골관절염 · 임상3상 · Licensed from Biosplice Therapeutics, Inc (formerly Samumed) on 2021-03-31; total milestone payments up to US$10,000,000 (US$3,000,000 paid as upfront).

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 31 more patents

AI reads

MAA server logs · IP-verified
78
Times AI engines pulled SAMIL PHARMACEUTICAL CO.,LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

77
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

12
live 0
Last 7 days
55
live 0
Last 30 days
78
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot71
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 26, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for SAMIL PHARMACEUTICAL CO.,LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

SHINHUNG CO.,LTD1 shared

Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition